Menno V Huisman

Hematology — Leiden University Medical Center, Netherlands

LeadR Profile

Menno V Huisman Leiden University Medical Center Netherlands
2 605 ScienceLeadR Reputation 2605
Network Map

Hematology

Subspecialties: Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

Leiden University Medical Center

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 732

Citations

Citations: 57 412 1st author: 41 Last author: 180 Unique author: 20


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
DUTCH weight control in atrial fibrillation study (DUTCH-WAIST) : Design and rationale of a randomised controlled trial.
life style, electric countershock, atrial fibrillation, overweight, weight control, semaglutide
Neth Heart J20260
Development and External Validation of the GLORIA-AF Bleeding Weighted Risk Score for Patients with Atrial Fibrillation.
registries, hemorrhage, cardiovascular diseases, atrial fibrillation
Eur J Prev Cardiol20260
Development and Validation of the GLORIA-AF Stroke Weighted Risk Score for Patients with Atrial Fibrillation.
stroke, atrial fibrillation
Europace20260
Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism.
anticoagulants, thromboembolism, hemorrhage, incidence, intracranial hemorrhages, therapeutics, venous thromboembolism
Haematologica20260
Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS project.
anticoagulants, thromboembolism, hemorrhage, decision making, shared, decision making, biomarkers, therapeutics, venous thromboembolism, thrombosis, prognosis, hemostasis
Thromb Haemost20260

Clinical Studies 23

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 11
Phase 4 6
Phase 3 5
Phase 2/Phase 3 1

By status:

Completed 16
Active not recruiting 3
Recruiting 2
Terminated 2

By type:

Interventional 19
Observational 4

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 3
multicentricup10 16

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
inDividual Targeted thrombosIS Prophylaxis Versus the Standard One Size Fits All Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT06581965 — arthroplasty, anticoagulants, thromboembolism, embolism, surgical wound, hemorrhage, hospitalization, rivaroxaban, venous thrombosis, multiple chronic conditions, kidney, pulmonary embolism, precision medicine, therapeutics, venous thromboembolism, thrombosis, blood platelets, heparin, low-molecular-weight, arthroplasty, replacement, knee, veins, dabigatran, direct-acting oral anticoagulants, apixaban
Phase 4Recruiting2024
Leiden Thrombosis Recurrence Risk Prevention
NCT06087952 — anticoagulants, thromboembolism, embolism, hemorrhage, venous thrombosis, pulmonary embolism, therapeutics, venous thromboembolism, thrombosis, veins
N/AActive not recruiting2021
Pulmonary Embolism International THrOmbolysis Study 3
NCT04430569 — embolism, plasminogen, plasminogen activators, tissue plasminogen activator, pulmonary embolism, therapeutics, tissues, infusions, intravenous
Phase 3Active not recruiting2021

LeadR Networks

Main global connection map